Literature DB >> 17020464

Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland.

Simon C Ramsden1, Zandra Deans, David O Robinson, Roger Mountford, Erik A Sistermans, Wayne W Grody, Shirley McQuaid, Simon J Patton, Susan A R Stenhouse.   

Abstract

Molecular genetic techniques have entered many areas of clinical practice. Public expectations from this technology are understandably high. To maintain confidence in this technology, laboratories must implement the highest standards of quality assurance (QA). External quality assessment (EQA) is recognized as an essential component of QA. The United Kingdom National External Quality Assessment Service (UKNEQAS) for Molecular Genetics, first set up in 1991, is currently the longest provider of EQA to molecular genetic testing laboratories in the UK, The Netherlands, and Ireland. Errors in the scheme are sporadic events. However, evidence from this and other EQA schemes suggests that a residual error rate persists, which should be taken into account in clinical practice. This EQA scheme has evolved from the respective scientific bodies of the constituent countries and retains a strong emphasis on collective peer review. It is essential that the steps taken to ensure quality in this rapidly expanding field are clear and transparent to participants and public alike. We describe the procedures developed and the governance imposed to monitor and improve analytical and reporting standards in participant laboratories and we compare our experiences with those of equivalent EQA services in the United States.

Entities:  

Mesh:

Year:  2006        PMID: 17020464     DOI: 10.1089/gte.2006.10.147

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  9 in total

1.  Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories.

Authors:  Jana Camajova; Sarah Berwouts; Gert Matthijs; Milan Macek; Elisabeth Dequeker
Journal:  Eur J Hum Genet       Date:  2008-12-03       Impact factor: 4.246

2.  The experience of 3 years of external quality assessment of preimplantation genetic diagnosis for cystic fibrosis.

Authors:  Zandra Deans; Francesco Fiorentino; Anil Biricik; Joanne Traeger-Synodinos; Céline Moutou; Martine De Rycke; Pamela Renwick; Sioban Sengupta; Veerle Goossens; Gary Harton
Journal:  Eur J Hum Genet       Date:  2012-11-14       Impact factor: 4.246

Review 3.  Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.

Authors:  Lisa V Kalman; Ira M Lubin; Shannon Barker; Desiree du Sart; Rob Elles; Wayne W Grody; Mario Pazzagli; Sue Richards; Iris Schrijver; Barbara Zehnbauer
Journal:  Arch Pathol Lab Med       Date:  2013-07       Impact factor: 5.534

4.  Preparation and validation of the first WHO international genetic reference panel for Fragile X syndrome.

Authors:  Malcolm Hawkins; Jennifer Boyle; Kathleen E Wright; Rob Elles; Simon C Ramsden; Anna O'Grady; Michael Sweeney; David E Barton; Trent Burgess; Melanie Moore; Chris Burns; Glyn Stacey; Elaine Gray; Paul Metcalfe; J Ross Hawkins
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

5.  Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment data.

Authors:  Sarah Berwouts; Emmanuelle Girodon; Martin Schwarz; Manfred Stuhrmann; Michael A Morris; Elisabeth Dequeker
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

6.  Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.

Authors:  Misha Angrist; Subhashini Chandrasekharan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.864

7.  Development and implementation of the quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network in mainland China.

Authors:  Rongbao Gao; Yan Gao; Leying Wen; Ming Shao; Shumei Zou; Changgui Li; Lei Yang; Xiyan Li; Wei Wang; Yuelong Shu
Journal:  BMC Infect Dis       Date:  2011-03-16       Impact factor: 3.090

Review 8.  Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation.

Authors:  Elisa De Paolis; Paola Concolino; Maria Elisabetta Onori; Concetta Santonocito; Claudia Marchetti; Anna Fagotti; Giovanni Scambia; Andrea Urbani; Angelo Minucci
Journal:  Mol Biol Rep       Date:  2021-10-13       Impact factor: 2.316

9.  The Italian National External quality assessment program in molecular genetic testing: results of the VII round (2010-2011).

Authors:  F Censi; F Tosto; G Floridia; M Marra; M Salvatore; A M Baffico; M Grasso; M A Melis; E Pelo; P Radice; A Ravani; C Rosatelli; N Resta; S Russo; M Seia; L Varesco; V Falbo; D Taruscio
Journal:  Biomed Res Int       Date:  2013-01-29       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.